Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6203| Title: | Mechanisms Driving Resistance to Proteasome Inhibitors Bortezomib, Carfilzomib, and Ixazomib in Multiple Myeloma | Authors: | Craig Wallington-Gates | Issue Date: | 2021 | Publisher: | Springer International Publishing | Source: | Resistance to Targeted Anti-Cancer Therapeutics, 2021 | Journal Title: | Resistance to Targeted Anti-Cancer Therapeutics | DOI: | 10.1007/978-3-030-73440-4_4 | ISBN: | 9783030734398 9783030734404 |
metadata.dc.rights.holder: | Craig Wallington-Gates | Type: | Book chapter |
| Appears in Sites: | Sunshine Coast HHS Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.